Join LKC Technologies for an exclusive panel discussion featuring world-renowned researchers and experts in ophthalmology, optic neuropathy, and psychiatric disorders. LKC Technologies’ Dr. Quentin Davis, Ph.D., will lead the discussion with Dr. Randy Kardon M.D. Ph.D. (University of Iowa, USA), Dr. Omar Mahroo (Moorfields Eye Hospital and St Thomas’ Hospital, London, UK), and Dr. Steven Silverstein, Ph.D. (Rutgers University, USA).
These experts in their fields are conducting some of the most innovative research studies around the world utilizing flash and flicker ERG testing.
Panelists and attendees will discover and discuss:
- What’s new in electrophysiology research
- Effects of pupillary response with ERGs
- Review of Photopic Negative Response (PhNR) testing in regards to pupil-light reflex and optic neuropathies
- Heritability study of identical and fraternal twins to identify the genetic contribution to inter-person variability in ERG responses
- The future of ERG research for various diseases including diabetic retinopathy, Birdshot uveitis, and mental health disorders such as schizophrenia
Don’t miss this exclusive event and opportunity to network with some of the premiere researchers in the world.
Monday, May 8, 2017
7:00 PM – 9:00 PM ET
Sullivan’s Steakhouse Library Room
One East Pratt Street, Suite 102| Baltimore, MD 21202
Walking distance from the 2017 ARVO show at the Baltimore Convention Center (see map here)
Light hors d’oeuvres will be served.
Can’t make it? Event full? LKC will be taping the panel, please contact firstname.lastname@example.org if you would like to be sent the video when available.
ABOUT THE SPEAKERS
Dr. Quentin Davis, Ph.D. (Moderator)
Quentin is Vice President of Operations and Development responsible for the technical aspects for the company’s UTAS and RETeval® products. Quentin was previously involved in immunoassay, biological warfare detection, and in vitro diagnostic device development for 13 years before joining LKC in 2010. At LKC, he was the lead designer for the RETeval device and was a key member of the team that ran the 468 subject clinical trial on detecting diabetic retinopathy. His current focus is translating cutting-edge ERG research into clinically useful tools. Quentin is a published author and frequent presenter on various topics related to electrophysiology. He is a registered U.S. Patent Agent and is an inventor on 19 U.S. patent applications. Quentin holds BS, MS, and Ph.D. degrees from the Massachusetts Institute of Technology in Electrical Engineering and Computer Science.
Dr . Randy Kardon M.D. Ph.D. (University of Iowa, USA)
Randy Kardon M.D. Ph.D., is tenured Professor of Ophthalmology and Director of the Neuro-ophthalmology Service at the University of Iowa and Veterans Administration Hospitals. He holds the Pomerantz Family Chair in Ophthalmology and is Director of the Iowa City Veterans Administration Center for the Prevention and Treatment of Visual Loss. Dr. Kardon has published over 20 chapters, co-authored a textbook, and has published over 200 peer-reviewed journal articles. Dr. Kardon is presently the Principal Investigator or co-PI on 8 major grants externally funded by the Veterans Administration, NIH, and the Department of Defense, including funding as part of the Chronic Effects of Neurotrauma Consortium (CENC) for a prospective study entitled “Visual Sensory Impairments and Progression Following Mild Traumatic Brain Injury”. He has been funded for his research from the Department of Veterans Affairs since 1990, and was one of the first ophthalmologists to receive a VA Career Development Award. He did most all of his training (undergraduate, combined M.D.-Ph.D, residency and two year fellowship in neuro-ophthalmology at the University of Iowa, Iowa City, Iowa, USA, and started as faculty in Ophthalmology in 1989. Dr. Kardon currently teaches and mentors undergraduate students, medical students, and residents and has received a University of Iowa Collegiate Teaching Award for his teaching and commitment to education. He currently serves on the editorial board for the Journal of Neuro-ophthalmology. His main areas of current research interest include use of facial features to diagnose and monitor eye and neurological disorders, pupil physiology and its clinical application, diagnosis and treatment of light sensitivity, traumatic brain injury and its treatment, therapeutic interventions for preserving vision in blinding eye diseases, and investigating structure-function relationships in the visual system using optical coherence tomography (OCT), ocular blood flow, image analysis, and MRI. Dr. Kardon is actively involved in the development of telemedicine tools for objectively evaluating the status of the visual and neurological systems for testing in remote locations. He is cofounder of MedFace and FaceX, start-up companies that are developing low cost mobile devices for precise video assessment of facial responses to light stimuli to diagnose and monitor treatment of medical, neurological and eye disorders.
Dr. Omar Mahroo (Kings College, London, UK)
Dr. Mahroo is a retinal specialist working at Moorfields Eye Hospital and at St Thomas’ Hospital in London. His undergraduate degree, clinical medical degree and PhD were at the University of Cambridge, and his post-doctoral work was at Cambridge and at the Australian National University. He completed his ophthalmology training in London, and is a Fellow of the Royal College of Ophthalmologists. His research, now based at King’s College London and University College London, explores retinal function, particularly the application of retinal electrophysiology to advance our understanding of retinal mechanisms in health and disease.
Dr. Steven Silverstein, Ph.D. (Rutgers University, USA)
Dr. Steven Silverstein is Director of Research, and Director of the Division of Schizophrenia Research at Rutgers University Behavioral Health Care (UBHC), the Co-Director of the Rutgers-Princeton Center for Computational Cognitive Neuropsychiatry, and Professor of Psychiatry at Rutgers – Robert Wood Johnson Medical School. He is the former Chair of the American Psychological Association’s Task Force on Serious Mental Illness, and the current President of the Society for Research in Psychopathology. Dr. Silverstein received his Ph.D. in Psychology from the State University of New York at Buffalo in 1989, and completed his internship and fellowship at Cornell Medical College from 1988-1990. He has been at Rutgers since 2006 and since 2008 he has been Director of Research for UBHC. Dr. Silverstein has over 25 years of experience in treating people with schizophrenia and bipolar disorder, and has directed inpatient units and outpatient programs for these populations. Dr. Silverstein’s research interests are in the development of schizophrenia, perceptual and cognitive changes found in schizophrenia, and prediction of treatment response and relapse. He has over 200 publications related to schizophrenia, and is currently Principal Investigator (PI) or site PI on multiple (n=10) NIMH, state or foundation grants involving assessment and treatment. Dr. Silverstein is the recipient of many awards, including the United States Psychiatric Rehabilitation Association’s Armin Loeb Award for Research in Psychiatric Rehabilitation in 2008, The New Jersey Psychological Associations Distinguished Researcher Award in 2009, the American Psychological Foundation’s Alexander Gralnick Research Investigator Prize in 2010, and the Trailblazer Award from the Schizophrenia Special Interest Group of the Society for Advancement of Behavioral and Cognitive Therapy in 2016.
Check out ARVO research posters and presentations from the speakers:
Sunday, May 7th
Eye and Vision Trauma
New Approaches for Assessing the Short and Long Term Effects of Trauma on the Visual System
8:30am – 8:47am
University of Iowa
Presentation Number: 12a
Towards elucidation of the myopia signalling cascade: association of human cone system electrophysiological response parameters with a myopia susceptibility polymorphism
3:15pm – 5:00pm
Posterboard #: B0517
Abstract Number: 1097 – B0517
Author Block: Omar A. Mahroo1,2 , Ambreen Tariq3 , Taha Bhatti3 , Ting Shen3 , Katie M. Williams1,3 , Christopher J. Hammond1,3 , Pirro G. Hysi3
1 Ophthalmology, King’s College London, London, United Kingdom; 2 Retinal Service, Moorfields Eye Hospital, London, United Kingdom; 3 Twin Research and Genetic Epidemiology, King’s College London, London, United Kingdom
Wednesday, May 10th
Exploration of the phenomenon of regression to the mean in visual acuity measurements in patients with age-related macular degeneration
11:00am – 12:45pm
Posterboard Number: B0648
Abstract Number: 4696 – B0648
Author Block: Simona Degli Esposti1 , Omar A. Mahroo1 , Praveen J. Patel1 , Adnan Tufail1
1 NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital, London, United Kingdom
Three-Dimensional Bruch’s Membrane Shape Change Over Time with Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)
12:00pm – 12:15pm
Location: Room 324
Presentation Number: 4308
Author Block: Jui-Kai Wang1 , Caitlin M. Danielson1 , Randy Kardon2,3 , Patrick A. Sibony4 , Mark J. Kupersmith5 , Mona K. Garvin2,1
1 Electrical & Computer Eng, University of Iowa, Iowa City, Iowa, United States; 2 Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health System, Iowa City, Iowa, United States; 3 Ophthalmology and Medicine, University of Iowa, Iowa City, Iowa, United States; 4Ophthalmology, State University of NY at Stony Brook/UHMC, Stony Brook, New York, United States; 5 Mount Sinai West Hospital and NYEEI, New York, New York, United States
Flash and Pattern ERG Findings in Schizophrenia and Their Relationships to Visual Function
3:45pm – 5:30pm
Posterboard #: B0268
Abstract Number: 4879 – B0268
Author Block: Steven Silverstein1 , Docia Demmin1 , Roché Matthew1 , Quentin Davis2 , Frank Taranto3 , Aaina Menon1
1 Psychiatry, Rutgers University, Piscataway, New Jersey, United States; 2 LKC Technologies, Inc., Gaithersburg, Maryland, United States; 3 Diopsys, Inc., Pine Brook, New Jersey, United States
Normative parameters for rapid photopic electroretinogram recordings with a hand-held device: results from over 500 subjects
3:45 pm – 5:30 pm
Posterboard #: B0278
Abstract Number: 4889 – B0278
Author Block: Talha Soorma1,2 , Ibtesham Hossain1 , Ibrahim Sheriff1 , Noor Hassan1 , Diana Kozareva3 , Ekaterina Yonova3 , Yemi Adelaja3 , Miles Stanford1,3 , Katie M. Williams1,3 , Christopher J. Hammond1,3 , Omar A. Mahroo1,4
1 Ophthalmology, St. Thomas’ Hospital, London, United Kingdom; 2 Barts and The London School of Medicine and Dentistry, London, United Kingdom; 3 Department of Twin Research and Genetic Epidemiology, King’s College London, St Thomas’ Hospital Campus, Westminster Bridge Road, London, United Kingdom SE1 7EH, London, United Kingdom; 4 NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, 162 City Road, London, United Kingdom EC1V 2PD, London, United Kingdom
Relative genetic and environmental contributions to variations in electroretinogram responses quantified in a twin study
3:45pm – 5:30pm
Posterboard #: B0287
Abstract Number: 4898 – B0287
Author Block: Mohsin Patel1 , Taha Bhatti1,2 , Ambreen Tariq1 , Ting Shen1 , Katie M. Williams1,2 , Christopher J. Hammond1,2 , Omar A. Mahroo1,3
1 Ophthalmology, King’s College London, London, United Kingdom; 2 Twin Research and Genetic Epidemiology, King’s College London, London, United Kingdom; 3 NIHR BRC for Ophthalmology, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom
Thursday, May 11th
Is an electroretinogram in Sudden Acquired Retinal Disorder (SARDS) really flat?
8:30am – 10:15am
Posterboard #: B0436
Abstract Number: 5339 – B0436
Author Block: Olga Kraszewska1 , Brian Cichocki2 , Quentin Davis1
1 LKC Technologies Inc, Gaithersburg, Maryland, United States; 2 Texas Veterinary Ophthalmology, Fort Worth, Texas, United States